Change in Management - (1) Appointment of Additional Director (Executive)designated as MD & CEO and KMP; (2) Appointment of Independent Director (Non-Executive)
PROTEAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 18.3 pts more than Nifty Microcap 250 and 19.1 pts more than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Protean eGov Technologies held its Board meeting on May 20, 2026, approving multiple key items. The company reported FY2026 standalone revenue of Rs 996.43 crore, up 18.4% from Rs 841.37 crore in FY2025, with profit after tax of Rs 94.32 crore (vs Rs 92.58 crore). The Board recommended a 100% final dividend of Rs 10 per share. In management changes, Mr. Ajay Rajan (51), a senior banking professional from YES Bank and Deutsche Bank with 30+ years experience, has been appointed as MD & CEO effective June 1, 2026 for 3 years, subject to shareholder approval. Additionally, Mr. Nandkumar Saravade (64), former CEO of RBI's technology arm ReBIT and ex-Public Interest Director at BSE, has been appointed as Non-Executive Independent Director for 3 years. The appointment of Mr. Rajan as the new MD & CEO marks a leadership transition, while Mr. Saravade brings strong governance and cybersecurity expertise to the Board.
The appointment of an external banking professional as MD & CEO signals a potential strategic shift toward digital banking and fintech initiatives. The addition of an experienced independent director with regulatory and cybersecurity background strengthens corporate governance. Strong financial performance with revenue growth and dividend declaration are positive signals for shareholders.